Skip to Main Content
Welcome to the Scientist.com Marketplace

Go to Main Navigation

Elizabeth Tanner

Elizabeth Tanner is a freelance medical writer.
Showing 11-16 of 16 posts
Nov 12, 2013

This is Part 3 in a three-part series on key factors in CRO selection. (Check out Part 1 and Part 2). Use of CROs in research and drug development...

Nov 7, 2013

This is Part 2 in a three-part series on key factors in CRO selection. (Check out Part 1 and Part 3). Contract research organizations (CROs) often...

Nov 5, 2013

Successful life science startup entrepreneurs share the basics on starting a business. Aspiring entrepreneurs received advice from an optimistic...

Nov 1, 2013

Cell culture is the foundation of high throughput screening during drug development. However, it is well known that there is a big and precarious...

Oct 24, 2013

This is Part 1 in a three-part series on key factors in CRO selection. (Check out Part 2 and Part 3). Alternative strategies for approaching drug...

Oct 15, 2013

Amidst the many challenges facing the life sciences industry today such as diminishing funding sources, increased costs to develop new drugs and...